This is a high-performance PTCA (Percutaneous Transluminal Coronary Angioplasty) balloon dilatation catheter manufactured by IHT (Iberhospitex S.A. / Grupo IHT), a European (Spanish-based) medical device company specializing in interventional cardiology products. The device features a long, flexible blue hydrophilic-coated shaft for smooth navigation through tortuous coronary arteries, a semi-compliant or differentiated compliance balloon (behaves as SC at lower pressures and NC at higher pressures for versatile pre- and post-dilatation), a soft tapered distal tip with low entry/crossing profile (around 0.016"–0.023"), dual platinum-iridium radiopaque markers (gold/yellow visible) for precise positioning under fluoroscopy, and a standard proximal luer connector for inflation. It is indicated for treating ischemic heart disease/coronary artery disease by dilating stenotic segments, pre-dilating lesions before stenting, or post-dilating after stent deployment. Key advantages include cost-efficiency (reduced balloon usage per procedure), excellent pushability/trackability, and hybrid compliance for complex anatomies. Typical specs: shaft length ~141 cm, guidewire compatibility 0.014", nominal pressure 6–14 atm (depending on mode), rated burst pressure up to 20 atm.
IHT Central Asia LLP is a Kazakh-Spanish joint venture and the only manufacturer of coronary stents and balloon catheters in Central Asia, established in 2023. The company produces high-tech interventional cardiology devices based on European technology transfer. Production is localized in Astana and focused on treating ischemic heart disease and preventing myocardial infarction. Product range: Drug-eluting coronary stents (DEStiny) Balloon catheters for angioplasty (Evolve) Solutions for percutaneous coronary interventions Key advantages: Unique regional manufacturer Proven European technology and clinical validation Coverage of Kazakhstan demand (up to 36,000 stents/year) Up to 30% lower cost than imports Export to Central Asia and other markets IHT Central Asia delivers advanced cardiovascular solutions focused on technology, accessibility, and reliability for healthcare systems.
